[Federal Register: February 8, 2006 (Volume 71, Number 26)]
[Notices]
[Page 6510-6511]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr08fe06-126]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
    The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.


[[Page 6511]]


    Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel, Nanoscience-based Design of Therapies for Substance
Abuse Treatment.
    Date: February 15, 2006.
    Time: 12:30 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852 (Telephone Conference Call).
    Contact Person: Eric Zatman, Contract Review Specialist, Office
of Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1438.

    This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse Research Programs, National Institutes of Health,
HHS)

    Dated: February 1, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-1128 Filed 2-7-06; 8:45 am]

BILLING CODE 4140-01-M